Company Insider Tape

RECURSION PHARMACEUTICALS INC insider transactions

Executive and director filing history, acquisition and disposal balance, executive concentration, cadence, and stored market context.

Symbol RXRX Latest filing 7 Jul 2026

Company Read

Net disposal

RXRX has 33 stored insider filings. Acquisitions account for 39.4% of classified filings and disposals account for 60.6%. The largest stored filing is $190.6K from KHAN, NAJAT.

Latest filing 7 Jul 2026most recent stored row
Largest filing $190.6Kreported transaction value
Total filings 33stored transaction rows
Acquisition value $013 acquisitions
Disposal value $1.5M20 disposals
Net value $-1.5Macquisitions minus disposals

Filing cadence

Last 12 active months
Apr 2026 3
May 2026 12
Jun 2026 15
Jul 2026 3

Acquisitions 39.4% · Disposals 60.6%

Apr 2026 $144.4K
May 2026 $780.7K
Jun 2026 $384.8K
Jul 2026 $158.5K

Executive concentration

By filing count
GIBSON, CHRISTOPHER Director · 14 filings
BORGESON, BLAKE Director · 4 filings
BUMPUS, NAMANDJE Director · 3 filings
KHAN, NAJAT Director, CEO and President · 2 filings
TAYLOR, BEN R Chief Financial Officer · 2 filings
LI, DEAN Y Director · 2 filings
DAR, ZAVAIN Director · 2 filings
HALLETT, DAVID Chief Scientific Officer · 1 filings

Market Context

RXRX weekly market snapshot

Week 31 Jul 2026
Latest close 53.00 MXNstored weekly close
1-week move +0.0%latest weekly bar
13-week move -15.9%medium-term context
Relative Strength -31.5Sharemaestro indicator
Fair value gap -40.6%price vs fair value
Trend signal 0smoothed trend state

Transaction History

Latest insider filings for RXRX

Showing 31-33 of 33
Date 22 Apr 2026
Insider GIBSON, CHRISTOPHERDirector
Side Disposal
Shares 40000
Price 3.61
Value 144400
Security Class A Common Stock
Date 22 Apr 2026
Insider GIBSON, CHRISTOPHERDirector
Side Disposal
Shares 40000
Price 0.00
Value 0
Security Class B Common Stock
Date 22 Apr 2026
Insider GIBSON, CHRISTOPHERDirector
Side Acquisition
Shares 40000
Price 0.00
Value 0
Security Class A Common Stock